La Trobe University researchers have identified the formula that works best in early detection of breast cancer. [ + ]

The inaugural OMICS Australasia 2012 Symposium is being held from 26-28 November in Fremantle, Western Australia. It is being hosted by Murdoch University and supported by the Western Australian Department of Commerce, Bruker and other industry sponsors. [ + ]

A newly discovered gene that is essential for embryo survival could also hold the key to treating and potentially controlling chronic infections such as HIV, hepatitis and tuberculosis. [ + ]

Two Australian Synchrotron users are among the 12 winners of the prestigious Victoria Fellowships for 2012. [ + ]

A new type of stem cell could be developed into therapies for cardiovascular disease and other indications, and is being pursued by Australian biotech start-up Cynata. [ + ]

Researchers at KU Leuven, Ghent University and the University of Antwerp have discovered a way to make new zeolites quickly. They have experimentally demonstrated that it is possible to cut zeolite building blocks and rearrange them into a new structure. [ + ]

Biotech companies are exploring alternative options to supplement their in-house research and development, abandoning the traditional blockbuster drug model to instead pursue deals and buy their way to success, says new report. [ + ]

The Balnaves Foundation’s Young Researcher of the Year Awards have reached their fifth year, enabling young researchers to pursue innovative ideas in the quest for a cure for childhood cancer. [ + ]

Young scientist Miriam-Rose Ash has been awarded the Australian Synchrotron Thesis Medal for her study into the essential roles that iron and copper play in living organisms. [ + ]

People working in scientific research are invited to participate in a survey examining careers in the biological sciences and chemistry related research workforce. [ + ]

Bioniche (ASX:BNC) has selected an exclusive US distributor for canine cancer product Immunocidin, which launched in the market last month. [ + ]

Professor Terry Speed says the government funding bodies and research institutions need to do more to offer a clear and stable career path for new bioinformaticians. [ + ]

Alchemia (ASX:ACL) will receive $1.5m for the September quarter – its first proper share of the profits from sales of anticoagulant generic fondaparinux. [ + ]

Personalised medicine, translational research, a blood donor register and insectary for researching malaria are all part of an upgraded WEHI facility opened today. [ + ]

The Australian health and medical research community gathered to recognised its best and brightest at the Research Australia Awards for 2012. [ + ]